Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 09-2015 | 06-2015 | 12-2014 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 60,390 |
| Other current assets | 0 | 0 | 0 | 150 |
| TOTAL | $N/A | $N/A | $N/A | $60,540 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 0 | 0 | 0 | 70 |
| TOTAL | $N/A | $N/A | $N/A | $70 |
| Total Assets | $N/A | $N/A | $N/A | $61,490 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 920 |
| Accrued Expenses | N/A | N/A | N/A | 280 |
| Other current liabilities | N/A | N/A | N/A | 30 |
| TOTAL | $N/A | $N/A | $N/A | $1,250 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 1 |
| TOTAL | $N/A | $N/A | $N/A | $1 |
| Total Liabilities | $N/A | $N/A | $N/A | $1,250 |
| Shareholders' Equity | ||||
| Common Shares | N/A | N/A | N/A | 1 |
| Retained earnings | N/A | N/A | N/A | -23,690 |
| Other shareholders' equity | 0 | 0 | 0 | 82,009 |
| TOTAL | $N/A | $N/A | $N/A | $60,240 |
| Total Liabilities And Equity | $0 | $0 | $0 | $61,490 |